Dosing & Uses
Metastatic Breast Cancer
Pending FDA approval for metastatic breast cancer
Next:
Pharmacology
Mechanism of Action
Paclitaxel: Supports microtubule assembly by enhancing action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication; additionally, the drug can distort mitotic spindles, resulting in the chromosome breakage; may also suppress cell proliferation and modulate immune response
Encequidar: Binds to and inhibits P-gp, which prevents P-gp-mediated efflux of paclitaxel, therefore enhancing its oral bioavailability
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
